Skip to main content
Year archive

GlaxoSmithKline Pakistan Limited — 2018 filings

All 19 regulatory filings released by GlaxoSmithKline Pakistan Limited (GLAXO) in 2018, sourced directly from the official regulator.

19 Filings
2018 Period
2018 filings (19)
Filing Released Lang
Material Information - GlaxoSmithKline Pakistan Limited
Regulatory Filings
2018-12-31 English
Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations
Regulatory Filings
2018-12-10 English
Material Information
Regulatory Filings
2018-12-07 English
Transmission of Quarterly Report for the Period Ended 30 September 2018
Regulatory Filings
2018-10-30 English
Financial Results for the Quarter Ended 30 September 2018
Regulatory Filings
2018-10-29 English
Board Meeting
Regulatory Filings
2018-10-23 English
Material Information - Resignation of Mr. Husain Lawai, Independent Director and Chairman of the Audit Committee
Regulatory Filings
2018-09-11 English
ransmission of Quarterly Report for the Period Ended 30 Jun 2018
Regulatory Filings
2018-08-28 English
Financial Results for the Quarter Ended 30 June 2018
Regulatory Filings
2018-08-13 English
Board Meeting
Regulatory Filings
2018-08-06 English
Credit of Final Cash Dividend
Regulatory Filings
2018-05-15 English
Material Information
Regulatory Filings
2018-04-27 English
Financial Results for the Quarter ended 31 March 2018
Regulatory Filings
2018-04-24 English
Special Resolution - GSK Pakistan Limited
Regulatory Filings
2018-04-24 English
Board Meeting First Quarter Mar 2018
Regulatory Filings
2018-04-17 English
Notice of Annual General Meeting
Regulatory Filings
2018-04-03 English
Material Information
Regulatory Filings
2018-02-27 English
Financial Results for the Year Ended
Regulatory Filings
2018-02-27 English
Board Meeting
Regulatory Filings
2018-02-20 English